A drug used to treat leukemia can enhance the efficacy of immunotherapy for lung cancer, researchers at National Taiwan University Hospital (NTUH) found, saying that the discovery might increase the life expectancy of those with the disease.
The team led by Tsai Hsing-chen (蔡幸真), a doctor in the hospital’s internal medicine department, told a news conference in Taipei on Thursday that new treatments for lung cancer are urgently needed, adding that the disease kills more than 9,000 people per year in Taiwan, as it is often discovered at a late stage.
People with advanced lung cancer have in the past few years increasingly received immunotherapy, which seeks to boost the body’s immune defenses and has fewer side effects than chemotherapy, Tsai said.
However, immunotherapy is only suitable for about 50 percent of people with lung cancer, with long-lasting results for about 30 percent of those who receive it, NTUH thoracic oncology department director Shih Jin-yuan (施金元) said.
The hospital’s four-year research project sought to make immunotherapy an option for more people with the disease and increase its efficacy, NTUH said.
The team found that decitabine, a drug that blocks the activity of enzymes that facilitate the spread of cancer cells in myeloid leukemia patients, also increases the number of a certain type of receptor on the surface of lung cancer cells, Tsai said.
This made the cancer cells more vulnerable to the immune system’s gamma delta T cells, she added.
Although there is a limited number of gamma delta T cells in the body, the cells can be cultivated in the laboratory and administered together with decitabine, Tsai said.
In experiments on mice, the team found that the treatment reduced the size of lung tumors and increased life expectancy, she said.
The hospital is planning to apply for clinical trials, Tsai said, adding that similar treatments could be developed for other types of cancer, including colon and ovarian cancer.
The researchers’ findings were published in the peer-reviewed journal Nature Communications on Monday last week.
Fast food chain McDonald's is to raise prices by up to NT$5 on some products at its restaurants across Taiwan, starting on Wednesday next week, the company announced today. The prices of all extra value meals and sharing boxes are to increase by NT$5, while breakfast combos and creamy corn soup would go up by NT$3, the company said in a statement. The price of the main items of those meals, if ordered individually, would remain the same. Meanwhile, the price of a medium-sized lemon iced tea and hot cappuccino would rise by NT$3, extra dipping sauces for chicken nuggets would go up
FUKUOKA SITUATION: Japanese media reported that the pathogen is expected to be identified by the summer, while the CDC downplayed the idea that it was hMPV A “mysterious cold-like illness” reported in Japan’s Fukuoka Prefecture does not seem to be a new disease, but Japanese authorities have been asked about the situation, the Centers for Disease Control (CDC) said yesterday. The Fukuoka Prefectural Medical Association on Wednesday told a news conference that a “mystery cold” that has become a hot topic on social media is “highly likely to be caused by some kind of viral infection,” Japan’s KBC News reported. “Many people are experiencing symptoms starting with a sore throat, followed by a runny nose, phlegm and a severe cough,” KBC News reported, citing association officials. Health authorities are
Nvidia Corp CEO Jensen Huang (黃仁勳) arrived in Taiwan yesterday ahead of upcoming AI and technology events, saying he plans to meet with clients and Taiwan Semiconductor Manufacturing Co Chairman C.C. Wei (魏哲家) during his visit. After landing at Taipei Songshan Airport, Huang posed for photos with fans and handed out Yakult drinks to reporters and supporters waiting at the scene, saying he has “a lot to do” during the trip. Asked about reports that Nvidia’s planned headquarters site in Taipei’s Beitou Shilin Technology Park could break ground on May 27, Huang said that if the company holds an event, he would
Carrefour Taiwan is to begin using a new name from the start of July, but it cannot divulge the name until then, the chairman of the supermarket chain's parent company said today. President Chain Store Co chairman Lo Chih-hsien (羅智先) was asked by reporters after a shareholders' meeting to confirm whether the company has settled on a new name for the supermarket brand. In March, the government-registered name of two Carrefour Taiwan branches was quietly changed to "Le Chia Kang" (樂家康) in Chinese, raising speculation that has been selected as the name. Lo said that because of local regulations and contractual obligations, the
RSS